Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a 13.527\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a) C(=C/c1ccccc1)\CSc1nnc(-c2ccccn2)n1Cc1ccco1
b) COc1ccccc1NC(=O)c1ccc(NC(=O)CSc2nc(N)cc(=O)[nH]2)cc1
c) O=S(=O)(Nc1cccc2ncccc12)c1cccc(C(F)(F)F)c1
d) Cc1cc(OCC(=O)Nc2ccc3c(c2)OCCO3)ccc1Cl
e) O=C(Nc1ccc(-c2ccccc2)cc1)c1ccco1
Answer: b. COc1ccccc1NC(=O)c1ccc(NC(=O)CSc2nc(N)cc(=O)[nH]2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccccc1NC(=O)c1ccc(NC(=O)CSc2nc(N)cc(=O)[nH]2)cc1
COc1ccccc1NC(=O)c1ccc(NC(=O)CSc2nc(N)cc(=O)[nH]2)cc1
4-[[2-[(4-amino-6-oxo-1H-pyrimidin-2-yl)sulfanyl]acetyl]amino]-N-(2-methoxyphenyl)benzamide